Celltrion

068270 · KOSPI · Health Care · LARGE CAP

A new supply contract.

Celltrion disclosed a supply contract, worth US$198M, about 8.29% of its recent annual revenue, running through Dec 2029.

Supply contract(Supply contract signed)· FILED 2026-03-17· RCEPT 20260317800019

US$198MContract value
8.29%vs. recent revenue
Dec 2029Throughfrom Mar 2026

Converted at 1 USD ≈ ₩1,488.91 (filing-date rate, 2026-03-17 close)

What happened

Celltrion disclosed a supply contract, worth US$198M, about 8.29% of its recent annual revenue, running through Dec 2029.

For context, this single contract equals about 8.29% of the company's most recent annual revenue.

CounterpartyDisclosed
Contract valueUS$198M
vs. recent revenue8.29%
ThroughDec 2029 (from Mar 2026)
Filed2026-03-17, Supply contract signed
SourceDART rcept 20260317800019 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-17 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.